{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T15:10:04Z","timestamp":1746025804770,"version":"3.40.4"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T00:00:00Z","timestamp":1378684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0073505","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T22:40:21Z","timestamp":1378766421000},"page":"e73505","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-Term Valproate Treatment Increases Brain Neuropeptide Y Expression and Decreases Seizure Expression in a Genetic Rat Model of Absence Epilepsy"],"prefix":"10.1371","volume":"8","author":[{"given":"Johanna","family":"Elms","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim L.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"van Raay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Dedeurwaerdere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"E Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1523\/JNEUROSCI.5320-05.2006","article-title":"Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami","volume":"26","author":"J Brill","year":"2006","journal-title":"J Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(81)90288-2","article-title":"Effect of sodium valproate on hypothalamic neurons in vivo and in vitro","volume":"219","author":"F Baldino Jr","year":"1981","journal-title":"Brain Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/BF00964888","article-title":"Acute effects of sodium valproate and gamma-vinyl GABA on regional amino acid metabolism in the rat brain: incorporation of 2-[14C]glucose into amino acids","volume":"7","author":"AG Chapman","year":"1982","journal-title":"Neurochem Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/bdd.2510050412","article-title":"Distribution of sodium valproate and GABA metabolism in CNS of the rat","volume":"5","author":"C Hariton","year":"1984","journal-title":"Biopharm Drug Dispos"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neuropharm.2003.10.013","article-title":"Valproate reduced excitatory postsynaptic currents in hippocampal CA1 pyramidal neurons","volume":"46","author":"ED Martin","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)24966-7","article-title":"Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture","volume":"237","author":"MJ McLean","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"ref8","unstructured":"Thomas A, Mathews G, Ferrendelli J (1996) Mechanisms of action of antiepileptic drugs. In: Wyllie E, editor. The Treatment of Epilepsy: Principles and Practice. 2nd ed. Baltimore: Williams & Wilkins. 700\u2013711."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1528-1157.1992.tb02356.x","article-title":"Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): I. Antiepileptic actions","volume":"33","author":"U Altrup","year":"1992","journal-title":"Epilepsia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0006-8993(93)91534-Y","article-title":"Diffusion analysis of valproate and trans-2-en-valproate in agar and in cerebral cortex of the rat","volume":"631","author":"A Lucke","year":"1993","journal-title":"Brain Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0006-8993(87)90881-X","article-title":"Distributions of certain neuropeptides in the primate thalamus","volume":"426","author":"M Molinari","year":"1987","journal-title":"Brain Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cne.902900305","article-title":"Neuronal localisation of neuropeptide Y gene expression in rat brain","volume":"290","author":"BJ Morris","year":"1989","journal-title":"J Comp Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2004.11.022","article-title":"Neuropeptide Y suppresses absence seizures in a genetic rat model","volume":"1033","author":"LM Stroud","year":"2005","journal-title":"Brain Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2004.04.006","article-title":"Neuropeptide Y and epilepsy: recent progress, prospects and controversies","volume":"38","author":"SC Baraban","year":"2004","journal-title":"Neuropeptides"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(99)02119-8","article-title":"Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition","volume":"848","author":"JP Redrobe","year":"1999","journal-title":"Brain Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.nbd.2005.05.010","article-title":"Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors","volume":"20","author":"DP Woldbye","year":"2005","journal-title":"Neurobiol Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.peptides.2006.08.043","article-title":"NPY signaling through Y1 receptors modulates thalamic oscillations","volume":"28","author":"J Brill","year":"2007","journal-title":"Peptides"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1460-9568.2007.05348.x","article-title":"Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y2 receptors","volume":"25","author":"MJ Morris","year":"2007","journal-title":"Eur J Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1523\/JNEUROSCI.21-15-05804.2001","article-title":"Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy","volume":"21","author":"S Furtinger","year":"2001","journal-title":"J Neurosci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3940(91)90295-5","article-title":"Increased preproneuropeptide Y mRNA in the rat hippocampus during the development of hippocampal kindling: comparison with the expression of preprosomatostatin mRNA","volume":"132","author":"C Bendotti","year":"1991","journal-title":"Neurosci Lett"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0306-4522(95)00268-N","article-title":"Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy","volume":"69","author":"C Schwarzer","year":"1995","journal-title":"Neuroscience"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0079-6123(08)61263-7","article-title":"Seizures, neuropeptide regulation, and mRNA expression in the hippocampus","volume":"83","author":"C Gall","year":"1990","journal-title":"Prog Brain Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0143-4179(89)90045-0","article-title":"Somatostatin, neuropeptide Y, GABA and cholinergic enzymes in brain of pentylenetetrazol-kindled rats","volume":"14","author":"A Pitkanen","year":"1989","journal-title":"Neuropeptides"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0306-4522(92)90207-I","article-title":"Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat","volume":"50","author":"G Sperk","year":"1992","journal-title":"Neuroscience"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0169-328X(95)00033-O","article-title":"Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain","volume":"31","author":"O Zachrisson","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"ref26","first-page":"461","article-title":"Inhibitory effect of neuropeptide y on epileptiform activity in the frontal cortex and hippocampus in vitro","volume":"47","author":"M Bijak","year":"1995","journal-title":"Pol J Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.43.s.5.13.x","article-title":"Antiepileptic actions of neuropeptide Y in the mouse hippocampus require Y5 receptors","volume":"43","author":"SC Baraban","year":"2002","journal-title":"Epilepsia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1152\/jn.1997.78.3.1651","article-title":"Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro","volume":"78","author":"GJ Klapstein","year":"1997","journal-title":"J Neurophysiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1528-1167.2011.03370.x","article-title":"Focal administration of neuropeptide Y into the S2 somatosensory cortex maximally suppresses absence seizures in a genetic rat model","volume":"53","author":"L van Raay","year":"2012","journal-title":"Epilepsia"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nm0797-761","article-title":"Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors","volume":"3","author":"DP Woldbye","year":"1997","journal-title":"Nat Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hipo.10110","article-title":"Neuropeptide Y delays hippocampal kindling in the rat","volume":"13","author":"S Reibel","year":"2003","journal-title":"Hippocampus"},{"key":"ref32","first-page":"415","article-title":"Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature","volume":"381","author":"JC Erickson","year":"1996"},{"key":"ref33","first-page":"8927","article-title":"Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci","volume":"17","author":"SC Baraban","year":"1997"},{"key":"ref34","first-page":"237","article-title":"Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience","volume":"110","author":"A Vezzani","year":"2002"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Marescaux C, Vergnes M, Depaulis A (1992) Genetic absence epilepsy in rats from Strasbourg\u2013a review. J Neural Transm Suppl 35: 37\u201369.","DOI":"10.1007\/978-3-7091-9206-1_4"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1124\/jpet.106.104968","article-title":"The mechanism of carbamazepine aggravation of absence seizures","volume":"319","author":"L Liu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.tips.2003.08.006","article-title":"Pharmacology of absence epilepsy","volume":"24","author":"JP Manning","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2010.10.011","article-title":"Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy","volume":"20","author":"S Dedeurwaerdere","year":"2011","journal-title":"Seizure"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jneumeth.2009.01.024","article-title":"A novel system allowing long-term simultaneous video-electroencephalography recording, drug infusion and blood sampling in rats","volume":"179","author":"L van Raay","year":"2009","journal-title":"J Neurosci Methods"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/bdd.259","article-title":"Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding","volume":"22","author":"TL Arens","year":"2001","journal-title":"Biopharm Drug Dispos"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.nbd.2008.04.012","article-title":"Genetic absence epilepsy rats from Strasbourg have increased corticothalamic expression of stargazin","volume":"31","author":"KL Powell","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1528-1157.1979.tb04776.x","article-title":"The delayed effect of sodium valproate on the photoconvulsive response in man","volume":"20","author":"AJ Rowan","year":"1979","journal-title":"Epilepsia"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"W Loscher","year":"1999","journal-title":"Prog Neurobiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(79)90034-7","article-title":"Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo","volume":"59","author":"MJ Iadarola","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/0006-2952(85)90645-8","article-title":"In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities","volume":"34","author":"W Loscher","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(84)90509-9","article-title":"Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children","volume":"2","author":"W Loscher","year":"1984","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1528-1157.1985.tb05656.x","article-title":"Cerebrospinal fluid gamma-aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment","volume":"26","author":"W Loscher","year":"1985","journal-title":"Epilepsia"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1528-1157.1980.tb04314.x","article-title":"Increase of human plasma GABA by sodium valproate","volume":"21","author":"W Loscher","year":"1980","journal-title":"Epilepsia"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0024-3205(81)90504-X","article-title":"Plasma GABA levels in neurological patients under treatment with valproic acid","volume":"28","author":"W Loscher","year":"1981","journal-title":"Life Sci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"9639","DOI":"10.1523\/JNEUROSCI.23-29-09639.2003","article-title":"Target-specific neuropeptide Y-ergic synaptic inhibition and its network consequences within the mammalian thalamus","volume":"23","author":"QQ Sun","year":"2003","journal-title":"J Neurosci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2005.03.007","article-title":"Sleep, epilepsy and thalamic reticular inhibitory neurons","volume":"28","author":"M Steriade","year":"2005","journal-title":"Trends Neurosci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.nbd.2007.02.006","article-title":"Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation","volume":"26","author":"DI Sinn","year":"2007","journal-title":"Neurobiol Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"CJ Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"M Gottlicher","year":"2001","journal-title":"EMBO J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"OH Kramer","year":"2003","journal-title":"EMBO J"},{"key":"ref57","first-page":"647","article-title":"Regulation of the HIF-1alpha stability by histone deacetylases","volume":"17","author":"SH Kim","year":"2007","journal-title":"Oncol Rep"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.2005.03457.x","article-title":"Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells","volume":"95","author":"LM Castro","year":"2005","journal-title":"J Neurochem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1101\/lm.500907","article-title":"Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear","volume":"14","author":"TW Bredy","year":"2007","journal-title":"Learn Mem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"X Wu","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref61","first-page":"S127","article-title":"Endogenous control of hippocampal epileptogenesis: a molecular cascade involving brain-derived neurotrophic factor and neuropeptide Y. Epilepsia","volume":"41","author":"S Reibel","year":"2000"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1460-9568.2000.00941.x","article-title":"Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting","volume":"12","author":"S Reibel","year":"2000","journal-title":"Eur J Neurosci"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2007.04.001","article-title":"Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions","volume":"75","author":"SA Hamed","year":"2007","journal-title":"Epilepsy Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pediatrneurol.2009.06.003","article-title":"Metabolic alterations during valproic acid treatment: a prospective study","volume":"41","author":"A Abaci","year":"2009","journal-title":"Pediatr Neurol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/0269881108091595","article-title":"Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial","volume":"23","author":"CK Martin","year":"2009","journal-title":"J Psychopharmacol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2011.02.019","article-title":"Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity","volume":"13","author":"PT Chao","year":"2011","journal-title":"Cell Metab"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1523\/JNEUROSCI.4379-08.2009","article-title":"Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance","volume":"29","author":"L Yang","year":"2009","journal-title":"J Neurosci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0073505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T14:32:19Z","timestamp":1746023539000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0073505"}},"subtitle":[],"editor":[{"given":"Alice Y. W.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,9]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0073505","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2013,9,9]]}}}